Daniel Delaney

Daniel Delaney currently serves on the Board of Directors for RhythMedix and Vector Laboratories, Inc. Delaney's previous role as President and CEO of TECHLAB, Inc. spanned from September 2016 to March 2023. Prior to that, Delaney was a HealthCare Operating Executive at Pharos Capital Group and served as President of Eurofins Viracor, specializing in clinical diagnostics. Delaney also held the position of Chief Operating Officer at AccuVein Inc., leading operations for innovative medical imaging technology. Notable earlier roles include Senior Vice President and President of Alere North America, where responsibilities included global strategy and leadership of significant business units. Delaney's career began at Abbott, focusing on sales and marketing in various sectors. Daniel Delaney holds an MBA from Baruch College and a BA in Business and Economics from Saint Anselm College.